AQST
Aquestive Therapeutics Inc
4.70$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +27.9% | +1,807.4% | +29.2% | +0.8% | -22.0% | -12.8% | +10.9% | -6.2% | +6.1% | +13.8% | -22.6% | |
| – | +26.6% | +909.1% | +21.0% | +5.9% | -3.0% | -36.3% | +15.6% | +29.3% | +7.5% | -14.2% | -4.0% | |
| – | +29.8% | +3,142.4% | +33.0% | -1.4% | -30.6% | +2.0% | +9.0% | -21.1% | +5.2% | +33.4% | -31.0% | |
| – | +58.4% | +675.2% | +43.3% | +4.4% | -11.0% | -3.3% | -14.3% | +2.5% | -25.0% | +54.8% | -15.2% | |
| – | +53.2% | +84.2% | +20.5% | +188.2% | -11.0% | -13.1% | -4.3% | -1.1% | -40.0% | +58.0% | +59.1% | |
| – | +50.4% | +143.1% | +30.2% | +102.0% | -11.0% | -10.8% | -6.9% | -0.2% | -36.3% | +57.1% | +37.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +25.5% | +0.1% | +20.8% | +39.8% | +72.5% | -44.6% | -40.0% | +125.4% | +1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +27.5% | -161.4% | – | +49.4% | +103.5% | -70.3% | -95.8% | -105.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -12.9% | -2,062.0% | – | – | – | – | – | -2,351.8% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.